Generic Descovy is indicated for the treatment of HIV-1 Infection and for pre-exposure prophylaxis to reduce the risk of ...

Emtricitabine/tenofovir disoproxil fumarate are medications used to treat HIV. They are antiretroviral drugs combined in one tablet. The usual adult dose is one tablet taken once a day along with ...

This leaflet answers some common questions about TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200. It does not contain all the available information. It does not take the place of talking to ...

Merck & Co Inc (NYSE:MRK) revealed topline results from two pivotal Phase 3 trials of a two-drug regimen of ...

Emtricitabine and Tenofovir Alafenamide Tablets (RLD Descovy) had estimated annual sales of USD 3,556 million in the U.S.

The investigational therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor.

Mumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug ...

Table 3. Pediatric Studies Reporting The Effects of TDF on Renal Function Annual prevalence of proteinuria (urine protein/creatinine ratios >0.2) = 10.3–13.7%. Mean decline of BMDZ from baseline ...

Lupin is one of the first companies to receive approval for this formulation originally developed by Gilead Sciences, making ...

Researchers also found this option to be more effective than the PrEP option of taking emtricitabine–tenofovir disoproxil fumarate (Truvada) daily. The use of lenacapavir could greatly improve ...

Read this leaflet carefully before you start taking TENOFOVIR DISOPROXIL VIATRIS. Also, read it each time you get your TENOFOVIR DISOPROXIL VIATRIS prescription refilled, in case something has ...

This fixed-dose tablet combines 600mg efavirenz, 200mg emtricitabine (FTC), and 245mg tenofovir disoproxil fumarate (TDF). Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI), ...